| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |